Phreesia (NYSE:PHR) Insider Sells $518,639.85 in Stock

Phreesia, Inc. (NYSE:PHR) insider David Linetsky sold 17,445 shares of Phreesia stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $29.73, for a total transaction of $518,639.85. Following the transaction, the insider directly owned 174,002 shares of the company’s stock, valued at $5,173,079.46. The trade was a 9.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

David Linetsky also recently made the following trade(s):

• On Monday, August 18th, David Linetsky sold 78 shares of Phreesia stock. The stock was sold at an average price of $29.16, for a total transaction of $2,274.48.
• On Thursday, July 17th, David Linetsky sold 2,063 shares of Phreesia stock. The stock was sold at an average price of $26.89, for a total transaction of $55,474.07.
• On Friday, June 27th, David Linetsky sold 23,729 shares of Phreesia stock. The stock was sold at an average price of $28.50, for a total transaction of $676,276.50.
• On Wednesday, June 18th, David Linetsky sold 67 shares of Phreesia stock. The shares were sold at an average price of $25.61, for a total transaction of $1,715.87.
• On Tuesday, June 17th, David Linetsky sold 42 shares of Phreesia stock. The shares were sold at an average price of $25.17, for a total transaction of $1,057.14.

Phreesia Trading Up 1.5%

Shares of PHR traded up $0.46 during trading hours on Tuesday, reaching $30.85. 1,255,543 shares of the company traded hands, compared to its average volume of 528,061. The firm has a market cap of $1.84 billion, a price-to-earnings ratio of -41.68 and a beta of 0.71. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $31.46. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.02. The stock’s fifty day moving average price is $27.58 and its 200 day moving average price is $26.40.

Phreesia (NYSE:PHR) last issued its earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.06. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The firm had revenue of $115.94 million during the quarter, compared to analyst estimates of $115.00 million. During the same period in the previous year, the firm earned ($0.05) earnings per share. The business’s revenue was up 14.5% on a year-over-year basis. Phreesia has set its FY 2026 guidance at EPS. Sell-side analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Hedge Funds Weigh In On Phreesia

Several hedge funds have recently modified their holdings of PHR. Johnson Financial Group Inc. increased its holdings in Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock worth $28,000 after buying an additional 896 shares during the period. Quarry LP increased its holdings in Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock worth $71,000 after buying an additional 1,923 shares during the period. KBC Group NV acquired a new position in Phreesia in the 1st quarter worth approximately $74,000. Farther Finance Advisors LLC increased its holdings in Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after buying an additional 3,000 shares during the period. Finally, CWM LLC increased its holdings in Phreesia by 994.9% in the 1st quarter. CWM LLC now owns 4,040 shares of the company’s stock worth $103,000 after buying an additional 3,671 shares during the period. Institutional investors and hedge funds own 92.10% of the company’s stock.

Analyst Ratings Changes

PHR has been the subject of several analyst reports. Truist Financial increased their price target on shares of Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research report on Thursday, May 29th. Citigroup reissued a “buy” rating on shares of Phreesia in a research report on Wednesday, May 28th. Wall Street Zen upgraded shares of Phreesia from a “hold” rating to a “buy” rating in a report on Sunday, June 1st. Canaccord Genuity Group cut their price objective on shares of Phreesia from $35.00 to $34.00 and set a “buy” rating on the stock in a report on Thursday, May 29th. Finally, DA Davidson upgraded shares of Phreesia to a “strong-buy” rating in a report on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating and ten have issued a Buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $32.27.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.